Cargando…
Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions
Oncolytic viruses have the capacity to selectively kill infected tumor cells and trigger protective immunity. As such, oncolytic virotherapy has become a promising immunotherapy strategy against cancer. A variety of viruses from different families have been proven to have oncolytic potential. Seneca...
Autores principales: | Luo, Dankun, Wang, Haiwei, Wang, Qiang, Liang, Wenping, Liu, Bo, Xue, Dongbo, Yang, Yang, Ma, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968071/ https://www.ncbi.nlm.nih.gov/pubmed/35371972 http://dx.doi.org/10.3389/fonc.2022.839536 |
Ejemplares similares
-
Combination Analysis of Ferroptosis and Immune Status Predicts Patients Survival in Breast Invasive Ductal Carcinoma
por: Yang, Yang, et al.
Publicado: (2023) -
Global trends of Vaccinia oncolytic virus therapy over the past two decades: Bibliometric and visual analysis
por: Bo, Liu, et al.
Publicado: (2023) -
The Oncolytic Virus in Cancer Diagnosis and Treatment
por: Cao, Guo-dong, et al.
Publicado: (2020) -
The nomogram based on the 6-lncRNA model can promote the prognosis prediction of patients with breast invasive carcinoma
por: Luo, Dankun, et al.
Publicado: (2021) -
Engineering His-Tagged Senecavirus A for One-Step Purification of Viral Antigens
por: Fan, Junhao, et al.
Publicado: (2022)